Search research articles
Contact Us
Filters
Showing results (171-180 of 185) with videos related to
Page
of 19
Sort By:
International Journal of Clinical Oncology
|
August 7, 2024
Efficacy of robot-assisted partial nephrectomy compared to conventional laparoscopic partial nephrectomy for completely endophytic renal tumor: a multicenter, prospective study
Nobuyuki Hinata, Sae Murakami, Yuzo Nakano, et al.
Urology Journal
|
September 21, 2022
A Multicenter, Prospective, Non-randomized Study Evaluating Surgical hand Preparation between Double-Gloving and Single-Gloving for Preventing Postoperative Infection in Robotic and Laparoscopic Minimally Invasive Surgeries
Takashi Nagai, Kazumi Taguchi, Teruki Isobe, et al.
Cancers
|
May 4, 2026
Durable Progression-Free and Treatment-Free Survival After Nivolumab Plus Ipilimumab Therapy in Metastatic Renal Cell Carcinoma: A Real-World Study with a 5-Year Minimum Follow-Up
Hiroaki Ikoma, Shuzo Hamamoto, Yoshihiko Tasaki, et al.
Plos One
|
March 9, 2023
Quantitative analysis of calcium oxalate monohydrate and dihydrate for elucidating the formation mechanism of calcium oxalate kidney stones
Mihoko Maruyama, Koichi P Sawada, Yutaro Tanaka, et al.
Cancer Medicine
|
July 1, 2026
Elevation of Eosinophil Proportion After Pembrolizumab Increases the Risk of Immune-Related Adverse Events in Patients With Bladder Cancer
Kunihiro Odagiri, Yoshihiko Tasaki, Taku Naiki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 6, 2023
Elevated eosinophils proportion as predictor of immune-related adverse events after ipilimumab and nivolumab treatment of advanced and metastatic renal cell carcinoma
Yoshihiko Tasaki, Shuzo Hamamoto, Yosuke Sugiyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 7, 2023
Hemoglobin and neutrophil levels stratified according to International Metastatic Renal Cell Carcinoma Database Consortium risk predict the effectiveness of ipilimumab plus nivolumab in patients with advanced metastatic renal cell carcinoma
Nami Tomiyama, Yoshihiko Tasaki, Shuzo Hamamoto, et al.
The Canadian Journal of Urology
|
September 5, 2025
Associations between ureteral stent indwelling time, patient characteristics, and stent pain from an international prospective registry
Connor M Forbes, Ben H Chew, K F Victor Wong, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 11, 2025
Summary of the clinical practice guideline for the management of urinary stones, third edition
Katsuhito Miyazawa, Satoshi Yamaguchi, Taro Iguchi, et al.
Asia-Pacific Journal of Clinical Oncology
|
April 29, 2024
Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients
Yoshihiko Tasaki, Nanami Ito, Yoshihisa Mimura, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 185) with videos related to
Sort By:
Page
of 19
International Journal of Clinical Oncology
|
August 7, 2024
Efficacy of robot-assisted partial nephrectomy compared to conventional laparoscopic partial nephrectomy for completely endophytic renal tumor: a multicenter, prospective study
Nobuyuki Hinata, Sae Murakami, Yuzo Nakano, et al.
Urology Journal
|
September 21, 2022
A Multicenter, Prospective, Non-randomized Study Evaluating Surgical hand Preparation between Double-Gloving and Single-Gloving for Preventing Postoperative Infection in Robotic and Laparoscopic Minimally Invasive Surgeries
Takashi Nagai, Kazumi Taguchi, Teruki Isobe, et al.
Cancers
|
May 4, 2026
Durable Progression-Free and Treatment-Free Survival After Nivolumab Plus Ipilimumab Therapy in Metastatic Renal Cell Carcinoma: A Real-World Study with a 5-Year Minimum Follow-Up
Hiroaki Ikoma, Shuzo Hamamoto, Yoshihiko Tasaki, et al.
Plos One
|
March 9, 2023
Quantitative analysis of calcium oxalate monohydrate and dihydrate for elucidating the formation mechanism of calcium oxalate kidney stones
Mihoko Maruyama, Koichi P Sawada, Yutaro Tanaka, et al.
Cancer Medicine
|
July 1, 2026
Elevation of Eosinophil Proportion After Pembrolizumab Increases the Risk of Immune-Related Adverse Events in Patients With Bladder Cancer
Kunihiro Odagiri, Yoshihiko Tasaki, Taku Naiki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 6, 2023
Elevated eosinophils proportion as predictor of immune-related adverse events after ipilimumab and nivolumab treatment of advanced and metastatic renal cell carcinoma
Yoshihiko Tasaki, Shuzo Hamamoto, Yosuke Sugiyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 7, 2023
Hemoglobin and neutrophil levels stratified according to International Metastatic Renal Cell Carcinoma Database Consortium risk predict the effectiveness of ipilimumab plus nivolumab in patients with advanced metastatic renal cell carcinoma
Nami Tomiyama, Yoshihiko Tasaki, Shuzo Hamamoto, et al.
The Canadian Journal of Urology
|
September 5, 2025
Associations between ureteral stent indwelling time, patient characteristics, and stent pain from an international prospective registry
Connor M Forbes, Ben H Chew, K F Victor Wong, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 11, 2025
Summary of the clinical practice guideline for the management of urinary stones, third edition
Katsuhito Miyazawa, Satoshi Yamaguchi, Taro Iguchi, et al.
Asia-Pacific Journal of Clinical Oncology
|
April 29, 2024
Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients
Yoshihiko Tasaki, Nanami Ito, Yoshihisa Mimura, et al.
Page
of 19